4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-15-027541
Chief Scientific Officer sold 5,500 shares at $106.81 ($587,455)
- Chief Scientific Officer acquired 5,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Scott · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-03-16 | Exercise or conversion : show line 1 in the form | +5,500 | $0.47 | $2,571 | 48,270 | D |
| 2015-03-16 | Sale : show line 2 in the form | −5,500 | $106.81 | $587,455 | 42,770 | D |
| Open-market sales · 5,500 sh · avg $106.81 · $587,455 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-03-16 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −5,500 | $0.47 | 2020-12-06 | 5,500 | 302,817 | D |
Loading xslF345X03/doc4.xml…